iManageCancer: Psycho-emotional and family resilience monitoring

Dr Chiara Renzi - European Institute of Oncology, Milan, Italy
iManageCancer: Psycho-emotional and family resilience monitoring ( Dr Chiara Renzi - European Institute of Oncology, Milan, Italy )
21 Jul 2017

Celebrating a 10 year partnership: ecancer and the IEO

Prof Gordon McVie - Editor in Chief, ecancer
Celebrating a 10 year partnership: ecancer and the IEO ( Prof Gordon McVie - Editor in Chief, ecancer )
19 Jul 2017

Improving care for cancer patients

Dr David Hui - MD Anderson Cancer Center, Houston, USA
Improving care for cancer patients ( Dr David Hui - MD Anderson Cancer Center, Houston, USA )
14 Jun 2017

Managing cancer and living meaningfully

Dr Gary M. Rodin - UHN Princess Margaret Hospital, Toronto, Canada
Managing cancer and living meaningfully ( Dr Gary M. Rodin - UHN Princess Margaret Hospital, Toronto, Canada )
14 Jun 2017

Findings of a phase I/II study of nivolumab in patients with virus-associated tumours

Dr Antoine Hollebecque - Institut Gustave Roussy, Paris, France
Findings of a phase I/II study of nivolumab in patients with virus-associated tumours ( Dr Antoine Hollebecque - Institut Gustave Roussy, Paris, France )
4 Jun 2017

Functions of BRCA1 and the implications for treatment

Dr Jo Morris - University of Birmingham, Birmingham, UK
Functions of BRCA1 and the implications for treatment ( Dr Jo Morris - University of Birmingham, Birmingham, UK )
15 May 2017

Centrosomes in ovarian cancer

Dr Fanni Gergely - CRUK Cambridge Institute
Centrosomes in ovarian cancer ( Dr Fanni Gergely - CRUK Cambridge Institute )
27 Apr 2017

Projections of cancer incidence and burden among the HIV-positive population in the United States through 2030

Jessica Yasmine Islam - University of North Carolina, Chapel Hill, USA
Projections of cancer incidence and burden among the HIV-positive population in the United States through 2030 ( Jessica Yasmine Islam - University of North Carolina, Chapel Hill, USA )
12 Apr 2017

Results of SUMMIT: a global phII trial of neratinib in HER2/3 mutant solid tumours

Dr David Hyman - Memorial Sloan Kettering Cancer Center, New York, USA
Results of SUMMIT: a global phII trial of neratinib in HER2/3 mutant solid tumours ( Dr David Hyman - Memorial Sloan Kettering Cancer Center, New York, USA )
10 Apr 2017

Neratinib in HER2 or HER3 mutant solid tumours

Dr David Hyman - Memorial Sloan Kettering Cancer Center, New York, USA
Neratinib in HER2 or HER3 mutant solid tumours ( Dr David Hyman - Memorial Sloan Kettering Cancer Center, New York, USA )
10 Apr 2017

Cervical cancer reduction with HPV vaccines

Dr Neerja Bhatla - All India Institute Of Medical Science, Delhi, India
Cervical cancer reduction with HPV vaccines ( Dr Neerja Bhatla - All India Institute Of Medical Science, Delhi, India )
29 Mar 2017

Perspectives on cervical cancer guidelines and vaccination in India

Dr Supriya Chopra - Tata Memorial Centre, Mumbai, India
Perspectives on cervical cancer guidelines and vaccination in India ( Dr Supriya Chopra - Tata Memorial Centre, Mumbai, India )
29 Mar 2017